Vir Biotech earnings, Revenue beat in Q3

  • Investing.com
Vir Biotech earnings, Revenue beat in Q3

Investing.com - Vir Biotech reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Vir Biotech announced earnings per share of $1.30 on revenue of $374.6M. Analysts polled by Investing.com anticipated EPS of $-0.42 on revenue of $146.35M.

Vir Biotech shares are up 18% from the beginning of the year and are trading at $23.18 , down-from-52-week-high.

Vir Biotech shares gained 6.33% in after-hours trade the report.

Vir Biotech follows other major Healthcare sector earnings this month

Vir Biotech's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.

J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles